IN THE NEWS

In the News    |    Press Releases

2025

Parkinson’s disease impacts nearly 80,000 Floridians, it’s a condition that damages dopamine production in the brain, affecting movement, balance and much more. With cases on the rise, it’s urgently in need of a cure.

Tiffany Kenney, news anchor at WPBF 25, recently visited the lab of Matthew Disney, Ph.D., Chemistry Department chair at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, for an up-close look at his work developing a treatment that targets the cause of Parkinson’s. Watch the piece here: https://www.wpbf.com/article/florida-parkinsons-research-in-jupiter-targets-diseases-root-cause/64621111
Disney’s Parkinson’s research is funded by the National Institutes of Health and the nonprofit SPARK NS, dedicated to advancing lab discoveries in neuroscience to the clinic.

2023

WPLG Local 10 – Interview on cancer RNA degrading medicines

Episode 2 of Research Detectives premiers Health Channel of South Florida PBS Matthew Disney, who recently showed that degrading specific RNA can make cancer self-destruct South Florida PBS

2018

http://www.sun-sentinel.com/business/fl-bz-scripps-company-spinoff-20180103-story.html
South Florida Sun Sentinel / January 3, 2018

http://www.sandiegouniontribune.com/business/biotech/sd-me-biotech-financing-20180103-story.html
San Diego Union-Tribune / January 3, 2018

https://www.xconomy.com/san-diego/2018/01/03/in-quest-to-drug-rna-with-small-molecules-expansion-pulls-in-55m/
Xconomy / January 3, 2018

https://cen.acs.org/articles/96/i2/Expansion-Therapeutics-launches-target-RNA.html
C&EN / January 3, 2018

https://endpts.com/upstart-expansion-bags-a-55m-launch-round-to-join-the-hunt-for-rna-targeting-small-molecules/
Endpoints News / January 3, 2018

http://www.finsmes.com/2018/01/expansion-therapeutics-closes-55-3m-series-a-financing.html
FINSMES / January 3, 2018

https://www.biospace.com/article/unique-new-socal-biotech-launches-with-55-3m-backed-by-novartis-sanofi-and-5am-ventures/
Biospace / January 3, 2018

2017

Small Molecules Against RNA Targets Attract Big Backers.
Nature / November 28, 2017

The RNA Drug Hunters: Academics, Biotech Start-Ups, and Big Pharma Companies Are Designing Small Molecules That Target RNA.
Chemical & Engineering News / November 27, 2017

America’s Top Young Researchers Named Finalists for 2017 Blavatnik National Awards for Young Scientists
NewsWise / May 31, 2017

Potential Drug Candidates Halt Prostate and Breast Cancer Growth.
Science Daily / March 9, 2017

A New Model of C9orf72 ALS Cycles In.
The ALS Research Forum / February 15, 2017

2016

Two TSRI Chemists Named Finalists for Blavatnik Awards
NewsWise / June 3, 2016

Scientists Create Compound That Erases Disease-Causing RNA Defect
Bioscience Technology / June 2, 2016

Scripps Florida Scientists Pioneer a Breakthrough Approach to Breast Cancer Treatment
EurekAlert! / May 9, 2016

In the News    |    Press Releases